Low serum testosterone levels are predictive of prostate cancer Luigi MeariniAlessandro ZucchiMassimo Porena Original Article 09 November 2011 Pages: 247 - 252
Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer Thomas SchnoellerFlorian JentzmikAndres J. Schrader Original Article 05 July 2012 Pages: 253 - 259
Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer Tim M. van der SluisIrene V. BijnsdorpAndré N. Vis Original Article 19 October 2012 Pages: 261 - 266
Circulating sex steroids and prostate cancer: introducing the time-dependency theory Andrea SaloniaFiras AbdollahFrancesco Montorsi Original Article 03 January 2013 Pages: 267 - 273
Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy Andrea SaloniaFiras AbdollahFrancesco Montorsi Original Article 24 March 2012 Pages: 275 - 280
Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer Jiunn-Bey PaoYing-Pi YangBo-Ying Bao Original Article 23 December 2011 Pages: 281 - 287
Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control Stanislav ZiaranFrederico Manuel GoncalvesJan Breza Sr Original Article 17 August 2012 Pages: 289 - 292
Long-term PSA-free survival and castration-free survival with delayed antiandrogen therapy in patients with one versus two or more positive nodes at prostatectomy Michele LoddeLouis LacombeYves Fradet Original Article 24 January 2012 Pages: 293 - 297
Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome Stepan VeselyLadislav JarolimMarko Babjuk Original Article 10 June 2012 Pages: 299 - 304
Diagnostic significance of [−2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0–10.0 ng/mL range Kazuto ItoMai MiyakuboKazuhiro Suzuki Original Article 18 August 2012 Pages: 305 - 311
Association between percent-free prostate-specific antigen and glomerular filtration rate in transrectal ultrasound-guided biopsy-proven patients with prostate-specific antigen levels ranging from 4 to 10 ng/ml Jae Heon KimJi Sung ShimJae Young Park Original Article 03 January 2013 Pages: 313 - 318
Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer Maxim RybalovAnthonius J. BreeuwsmaIgle J. de Jong Original Article 20 July 2012 Pages: 319 - 323
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer Thomas K. HamiltonNianping HuD. Robert Siemens Original Article 02 March 2012 Pages: 325 - 330
Intratumoral acetic acid injection eradicates human prostate cancer tumors in a murine model Jasneet Singh BhullarGokulakkrishna SubhasVijay K. Mittal Original Article 02 December 2012 Pages: 331 - 337
A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSA Alexandra Masson-LecomteLaurent GuyAlexandre de la Taille Original Article 15 April 2012 Pages: 339 - 343
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression? Tilman TodenhöferJörg HennenlotterChristian Schwentner Original Article 11 March 2012 Pages: 345 - 350
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence Judith S. KnappSoum D. LokeshwarAxel S. Merseburger Original Article 15 August 2012 Pages: 351 - 358
Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness Yoshio OhnoJun NakashimaMasaaki Tachibana Original Article 03 November 2012 Pages: 359 - 364
When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool Cosimo De NunzioCostantino LeonardoAndrea Tubaro Original Article 11 May 2012 Pages: 365 - 369
Hemodynamic effects of orally administered delta-ALA during radical prostatectomy Volker EichhornAlexander MaerzAlwin E. Goetz Original Article 26 November 2011 Pages: 371 - 376
Prostatic peripheral nerve distribution may impact the functional outcome of nerve-sparing prostatectomy B. AmendJ. HennenlotterK. D. Sievert Original Article 01 December 2011 Pages: 377 - 382
Effect of dorsal vascular complex size on the recovery of continence after radical prostatectomy Chang Wook JeongJong Jin OhSang Eun Lee Original Article 24 March 2012 Pages: 383 - 388
Prospective comparison of scar-related satisfaction and quality of life after laparoscopic versus open radical prostatectomy: no differences from patients’ point of view Nicolas Barry DelongchampsOlivier BelasMichaël Peyromaure Original Article 06 April 2012 Pages: 389 - 393
Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term results Jonas BuschCarsten StephanAhmed Magheli Original Article 11 May 2012 Pages: 395 - 401
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review Max PetersMaaike R. MomanMarco van Vulpen Original Article 18 August 2012 Pages: 403 - 409
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma Alessia GuarneriAngela BotticellaUmberto Ricardi Original Article 26 August 2012 Pages: 411 - 415
Pudendal nerve block in HDR-brachytherapy patients: do we really need general or regional anesthesia? Marcus SchenckCatarina SchenckRoberto Rossi Original Article 16 November 2012 Pages: 417 - 421
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results Gunnar LohmDirk BottkeThomas Wiegel Original Article 30 March 2012 Pages: 423 - 428
